| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/1995 | CA1334577C Method of preventing pneumocystis carinii pneumonia using pentamidine in an aerosol form |
| 02/28/1995 | CA1334576C Antiviral pharmaceutical compositions and process for preparing same |
| 02/28/1995 | CA1334575C Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts |
| 02/28/1995 | CA1334574C Azithromycin and derivatives as antiprotozoal agents |
| 02/28/1995 | CA1334573C Aqueous antimicrobial ophthalmic solutions |
| 02/27/1995 | CA2130859A1 Thienopyrimidine derivatives, their production and use |
| 02/27/1995 | CA2130793A1 Heterocyclic thrombin inhibitors |
| 02/27/1995 | CA2130770A1 Treatment of upper respiratory tract infections |
| 02/26/1995 | CA2130617A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
| 02/26/1995 | CA2130615A1 Methods of inhibiting vascular restenosis |
| 02/26/1995 | CA2130385A1 Inhibition of phosphatidylinositol 3-kinase with 17.beta.-hydroxywortmannin and analogs thereof |
| 02/24/1995 | CA2130503A1 Process for the manufacture of phenoxyphenoxyalkyl derivatives |
| 02/23/1995 | WO1995005465A1 Erythropoietin analogs |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005456A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 02/23/1995 | WO1995005455A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 02/23/1995 | WO1995005412A1 Cosmetic melanins |
| 02/23/1995 | WO1995005389A1 Sequence-specific glycoconjugate transcriptional antagonists |
| 02/23/1995 | WO1995005386A1 Phenethylamine compounds |
| 02/23/1995 | WO1995005383A1 Vasocontrictive dihydrobenzopyran derivatives |
| 02/23/1995 | WO1995005381A1 Vasoconstrictive substituted dihydropyranopyridines |
| 02/23/1995 | WO1995005379A1 Antipsychotic method |
| 02/23/1995 | WO1995005378A1 Antiviral thiazoles |
| 02/23/1995 | WO1995005377A1 Heterocycles useful as neurokinin antagonists |
| 02/23/1995 | WO1995005376A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
| 02/23/1995 | WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
| 02/23/1995 | WO1995005374A1 Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
| 02/23/1995 | WO1995005373A1 Novel quinolone carboxylic acid derivatives |
| 02/23/1995 | WO1995005366A1 Vasoconstrictive substituted aryloxyalkyl diamines |
| 02/23/1995 | WO1995005365A1 New bis-naphthalimides for the treatment of cancer |
| 02/23/1995 | WO1995005364A2 Inhibitors of biogenic amine transporters |
| 02/23/1995 | WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | WO1995005360A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
| 02/23/1995 | WO1995005359A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
| 02/23/1995 | WO1995005358A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect |
| 02/23/1995 | WO1995005198A1 Localanaesthetic preparation |
| 02/23/1995 | WO1995005188A1 Erection-inducing methods and compositions |
| 02/23/1995 | WO1995005186A1 Ruthenium red as an inhibitor of the immune response |
| 02/23/1995 | WO1995005185A1 Method of preventing neutrophil mediated connective tissue damage |
| 02/23/1995 | WO1995005184A2 Phosphate-binding polymers for oral administration |
| 02/23/1995 | WO1995005181A2 Drug for parasitic control of animals |
| 02/23/1995 | WO1995005180A1 Methods and compositions for inhibiting uridine secretion |
| 02/23/1995 | WO1995005179A1 Therapeutic combination containing an anti-varicella zoster virus compound and lamotrigine |
| 02/23/1995 | WO1995005178A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
| 02/23/1995 | WO1995005177A1 Remedy for nervous diseases |
| 02/23/1995 | WO1995005176A1 Use of ergoline derivatives for the treatment of glaucoma |
| 02/23/1995 | WO1995005175A1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases |
| 02/23/1995 | WO1995005174A1 Antipsychotic method |
| 02/23/1995 | WO1995005173A1 Oral compositions of h2-antagonists |
| 02/23/1995 | WO1995005172A1 Methods for modulating the human sexual response |
| 02/23/1995 | WO1995005171A1 Anti-mrsa composition |
| 02/23/1995 | WO1995005170A1 Methods of inhibiting hiv and inhibiting the activation of hiv |
| 02/23/1995 | WO1995005169A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity |
| 02/23/1995 | WO1995005168A1 Delayed release carnitine |
| 02/23/1995 | WO1995005167A2 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 02/23/1995 | WO1995005166A1 Procedure for encapsulating nsaids |
| 02/23/1995 | WO1995005164A1 Particles with modified physicochemical properties, their preparation and uses |
| 02/23/1995 | WO1995005156A1 Compositions for treating corns, calluses and warts |
| 02/23/1995 | WO1995005155A1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 02/23/1995 | WO1995005150A1 Sunscreen agents |
| 02/23/1995 | DE4327462A1 N-Acetyl-p-aminophenol derivatives for controlling pain |
| 02/23/1995 | DE3991484C2 Pharmaceutical composition containing a specific inhibitor of the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase |
| 02/23/1995 | CA2402590A1 Phospate-binding polymers for oral administration |
| 02/23/1995 | CA2169744A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
| 02/23/1995 | CA2169735A1 Oral compositions of h2-antagonists |
| 02/23/1995 | CA2169630A1 Compositions for treating corns, calluses and warts |
| 02/23/1995 | CA2169287A1 Inhibitors of biogenic amine transporters |
| 02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | CA2169187A1 Use of phenols and phenol derivatives as pharmaceutical agents with a fibrinogen-lowering action |
| 02/23/1995 | CA2169059A1 New bis-naphthalimides for the treatment of cancer |
| 02/23/1995 | CA2168211A1 Method of preventing neutrophil mediated connective tissue damage |
| 02/23/1995 | CA2167716A1 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 02/23/1995 | CA2167156A1 Bicyclo(2.2.2) octane derivatives cholecystokinin and/or gastin antagonists |
| 02/23/1995 | CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists |
| 02/22/1995 | EP0639644A1 New macrolides and their use |
| 02/22/1995 | EP0639580A1 Sphingoglycolipid |
| 02/22/1995 | EP0639577A1 Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents |
| 02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
| 02/22/1995 | EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it |
| 02/22/1995 | EP0639563A2 Use of cloprostenol, fluprostenol and their analogues for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension |
| 02/22/1995 | EP0639560A1 Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation |
| 02/22/1995 | EP0639552A1 Napthalenederivatives, their preparation and pharmaceutical compositions containing them |
| 02/22/1995 | EP0639380A1 Cyclodextrin inclusion product of taxol, process for producing the same, and its use |
| 02/22/1995 | EP0639377A1 Vitamin D compounds with anti-progesterone activity |
| 02/22/1995 | EP0639376A1 Liquid composition containing amide derivative |
| 02/22/1995 | EP0639375A1 A bile duct deterging composition |
| 02/22/1995 | EP0639374A2 New treatments using phenethyl derivatives |
| 02/22/1995 | EP0639373A1 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
| 02/22/1995 | EP0639201A1 14,16beta-ETHANO-15beta,16' -CYCLO-14beta-ESTRA-1,3,5(10)-TRIENES |
| 02/22/1995 | EP0639195A1 2-acyloxycephem derivatives as elastase inhibitors |
| 02/22/1995 | EP0639194A1 Cyclic ketal derivatives |
| 02/22/1995 | EP0639193A1 Esters of antibacterial condensed carbapeneme derivatives |
| 02/22/1995 | EP0639191A1 Indazol-3-one-2-yl derivatives of benzopyrans. |
| 02/22/1995 | EP0639187A1 Phenylderivate as inhibitors of atp citrate lyase |
| 02/22/1995 | EP0639186A1 Taxol derivatives |
| 02/22/1995 | EP0639184A1 New quinazolines as inhibitors of hiv reverse transcriptase |
| 02/22/1995 | EP0639183A1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents |
| 02/22/1995 | EP0639182A1 Quinoline derivatives |
| 02/22/1995 | EP0639181A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| 02/22/1995 | EP0639078A1 Method of treating eye disorders with silicone/fluorosilicone copolymer oil |